Aims: The aim of the present study was to investigate the anti‐Streptococcus mutans activity and the in vitro effects of subminimal inhibitory concentrations of guaijaverin isolated from Psidium guajava Linn. on cariogenic properties of Strep. mutans.
Methods and Results: Bioautography‐directed chromatographic fractionation, yield biologically active compound, quercetin‐3‐O‐α‐l‐arabinopyranoside (guaijaverin), from crude methanol extract of P. guajava. Growth‐inhibitory activity of the compound against Strep. mutans of both clinical and type strain cultures was evaluated. The anti‐Strep. mutans activity of the guaijaverin was found to be bacteriostatic, both heat and acid stable and alkali labile with the minimum inhibitory concentration (MIC) of 4 mg ml−1 for MTCC 1943 and 2 mg ml−1 for CLSM 001. The sub‐MIC concentrations (0·0078–2 mg ml−1) of the guaijaverin were evaluated for its cariogenic properties such as acid production, cell‐surface hydrophobicity, sucrose‐dependent adherence to glass surface and sucrose‐induced aggregation of Strep. mutans.
Conclusions: The active flavonoid compound, quercetin‐3‐O‐α‐l‐arabinopyranoside (guaijaverin) demonstrated high potential antiplaque agent by inhibiting the growth of the Strep. mutans.
Significance and Impact of the Study: This study demonstrated the new growth‐inhibitory compound guaijaverin against Strep. mutans and led to the acceptance of traditional medicine and natural products as an alternative form of health care.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.